When yellow jackets attack: Recurrent and severe anaphylactic reactions to insect bites and stings

American Journal of Hematology

Volumn 84, Issue 12, 2009, Pages 843-846

  Pollyea, Daniel A ^a   George, Tracy I ^a   Corless, Christopher ^b   Gotlib, Jason ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CD2 ANTIGEN; DIPHENHYDRAMINE; INTERLEUKIN 2 RECEPTOR ALPHA; LORATADINE; MONTELUKAST; PREDNISONE; RANITIDINE; STEM CELL FACTOR RECEPTOR; TRYPTASE; VENOM ANTISERUM;

ADULT; ANAMNESIS; ANAPHYLAXIS; BLOOD CELL COUNT; BONE MARROW BIOPSY; CASE REPORT; EOSINOPHIL; HUMAN; HUMAN TISSUE; HYMENOPTERA; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOTHERAPY; INSECT BITE; MALE; MAST CELL; MASTOCYTOSIS; MONOCLONAL MAST CELL ACTIVATION SYNDROME; NOTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN TEST; VESPULA MACULIFRON;

ANAPHYLAXIS; ANIMALS; EMERGENCIES; EPINEPHRINE; HUMANS; INJECTIONS, SUBCUTANEOUS; INSECT BITES AND STINGS; MALE; MIDDLE AGED; RECURRENCE; RHIPICEPHALUS SANGUINEUS; SYNCOPE; TRIATOMA; WASP VENOMS; WASPS;

EID: 73349085886     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21551     Document Type: Note

References (20)

1. Moffitt JE, Golden DB, Reisman RE, et al. Stinging insect hypersensitivity: A practice parameter update. J Allergy Clin Immunol 2004;114:869-886.
2. Antonicelli L, Bilo MB, Bonifazi F. Epidemiology of Hymenoptera allergy. Curr Opin Allergy Clin Immunol 2002;2:341-346.
3. Golden DB, Marsh DG, Kagey-Sobotka A, et al. Epidemiology of insect venom sensitivity. JAMA 1989;262:240-244.
4. Reisman RE. Insect stings. N Engl J Med 1994;331:523-527.
5. Lo Vecchio F, Tran TV. Allergic reactions from insect bites. Am J Emerg Med 2004;22:631.
6. Valls A, Pineda F, Belver M, et al. Anaphylactic shock caused by tick (Rhipicephalus sanguineous). J Invest Allergol Clin Immunol 2007;17:279-280.
7. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008;63:226-232.
8. Gonzalez de Olano D, de la Hoz Caballer B, Nunez Lopez R, et al. Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: A study of the Spanish network on mastocytosis (REMA). Clin Exp Allergy 2007;37:1547-1555.
9. Valent P, Akin C, Escribano L, et al. Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007;37:435-453.
10. Horny H.-P., Metcalfe DD, Bennett JM, et al. Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008:54-63.
11. Valent P, Horny HP, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: A consensus proposal. Leuk Res 2001;25:603-625.
12. Florian S, Krauth MT, Simonitsch-Klupp I, et al. Indolent systemic masto cytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes. Int Arch Allergy Immunol 2005; 136:273-280.
13. Corless CL, Harrell P, Lacouture M, et al. Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia. J Mol Diagn 2006;8:604-612.
14. Sotlar K, Horny HP, Simonitsch I, et al. CD25 indicates the neoplastic phenotype of mast cells: A novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens. Am J Surg Pathol 2004;28:1319-1325.
15. Sonneck K, Florian S, Mullauer L, et al. Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome. Int Arch Allergy Immunol 2007;142:158-164.
16. Akin C, Scott LM, Kocabas CN, et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis. Blood 2007;110:2331-2333.
17. Feger F, Ribadeau Dumas A, Leriche L, et al. Kit and c-kit mutations in mastocytosis: A short overview with special reference to novel molecular and diagnostic concepts. Int Arch Allergy Immunol 2002;127:110-114.
18. Akin C, Fumo G, Yavuz AS, et al. A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood 2004;103:3222-3225.
19. Bonadonna P, Perbellini O, Passalacqua G, et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 2009;123:680-686.
20. Sotlar K, Bache A, Stellmacher F, et al. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: A distinct subtype of systemic mastocytosis associated with a clonal hematological non-mast cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F. J Mol Diagn 2008;10:58-66.